Literature DB >> 34225539

Aberrations of DNA repair pathways in prostate cancer: a cornerstone of precision oncology.

Stergios Boussios1,2,3, Elie Rassy4, Sidrah Shah2, Evangelia Ioannidou5, Matin Sheriff2, Nicholas Pavlidis6.   

Abstract

Entities:  

Keywords:  BRCA; DNA damage repair; PARP; Prostate cancer; next-generation sequencing; precision oncology

Mesh：

Year:  2021        PMID： 34225539     DOI： 10.1080/14728222.2021.1951226

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN： 1472-8222            Impact factor:   6.902


× No keyword cloud information.
  10 in total

1.  Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer.

Authors:  Hiroko Kimura; Kei Mizuno; Masaki Shiota; Shintaro Narita; Naoki Terada; Naohiro Fujimoto; Keiji Ogura; Shotaro Hatano; Yusuke Iwasaki; Nozomi Hakozaki; Satoshi Ishitoya; Takayuki Sumiyoshi; Takayuki Goto; Takashi Kobayashi; Hidewaki Nakagawa; Toshiyuki Kamoto; Masatoshi Eto; Tomonori Habuchi; Osamu Ogawa; Yukihide Momozawa; Shusuke Akamatsu
Journal:  Br J Cancer       Date:  2022-08-19       Impact factor: 9.075

Review 2.  Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes.

Authors:  Sidrah Shah; Alison Cheung; Mikolaj Kutka; Matin Sheriff; Stergios Boussios
Journal:  Int J Environ Res Public Health       Date:  2022-07-01       Impact factor: 4.614

Review 3.  Androgen Receptor Gene Pathway Upregulation and Radiation Resistance in Oligometastatic Prostate Cancer.

Authors:  Helen Saxby; Stergios Boussios; Christos Mikropoulos
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

Review 4.  BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations.

Authors:  Sidrah Shah; Rachelle Rachmat; Synthia Enyioma; Aruni Ghose; Antonios Revythis; Stergios Boussios
Journal:  Int J Mol Sci       Date:  2021-11-23       Impact factor: 5.923

5.  miR-145-5p: A Potential Biomarker in Predicting Gleason Upgrading of Prostate Biopsy Samples Scored 3+3=6.

Authors:  Tao Wang; Lei Dong; Juanjuan Sun; Jialiang Shao; Jian Zhang; Siteng Chen; Chaofu Wang; Gangfeng Wu; Xiang Wang
Journal:  Cancer Manag Res       Date:  2021-12-10       Impact factor: 3.989

Review 6.  Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer.

Authors:  Antonios Revythis; Anu Limbu; Christos Mikropoulos; Aruni Ghose; Elisabet Sanchez; Matin Sheriff; Stergios Boussios
Journal:  Int J Environ Res Public Health       Date:  2022-07-14       Impact factor: 4.614

Review 7.  BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside.

Authors:  Stergios Boussios; Elie Rassy; Michele Moschetta; Aruni Ghose; Sola Adeleke; Elisabet Sanchez; Matin Sheriff; Cyrus Chargari; Nicholas Pavlidis
Journal:  Cancers (Basel)       Date:  2022-08-11       Impact factor: 6.575

Review 8.  DNA damage and metabolic mechanisms of cancer drug resistance.

Authors:  Deanna Tiek; Shi-Yuan Cheng
Journal:  Cancer Drug Resist       Date:  2022-05-05

9.  Case Report: Fluzoparib for multiple lines of chemotherapy refractory in metastatic cutaneous squamous cell carcinoma with BRCA2 pathogenic mutation.

Authors:  Xin Sun; Wenjuan Chen; Xiujuan Qu; Ying Chen
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

Review 10.  Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy.

Authors:  Aruni Ghose; Anita Bolina; Ishika Mahajan; Syed Ahmer Raza; Miranda Clarke; Abhinanda Pal; Elisabet Sanchez; Kathrine Sofia Rallis; Stergios Boussios
Journal:  Int J Environ Res Public Health       Date:  2022-09-23       Impact factor: 4.614
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.